Panitumumab

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2327 publications

Sotorasib and Panitumumab: A breakthrough in the treatment of KRAS-mutated mCRC.

Sotorasib and Panitumumab: A breakthrough in the treatment of KRAS-mutated mCRC.

Journal: JPMA. The Journal of the Pakistan Medical Association

Published: September 07, 2026

RAF/MEK Clamp Inhibition with Avutometinib and Cetuximab in RAF1 S257L-Mutated, Anti-EGFR-Refractory Metastatic Colorectal Cancer in Gaucher's disease.

RAF/MEK Clamp Inhibition with Avutometinib and Cetuximab in RAF1 S257L-Mutated, Anti-EGFR-Refractory Metastatic Colorectal Cancer in Gaucher's disease.

Journal: The oncologist

Published: July 08, 2026

Drug-induced paronychia: a disproportionality and time-to-onset pharmacovigilance study using FAERS and JADER.

Drug-induced paronychia: a disproportionality and time-to-onset pharmacovigilance study using FAERS and JADER.

Journal: Cutaneous and ocular toxicology

Published: July 07, 2026

Durable Response to Sotorasib Plus Panitumumab in NRAS G12C-Mutated, Microsatellite Instability-High (MSI-H) Rectal Cancer Refractory to Immunotherapy.

Durable Response to Sotorasib Plus Panitumumab in NRAS G12C-Mutated, Microsatellite Instability-High (MSI-H) Rectal Cancer Refractory to Immunotherapy.

Journal: Cureus

Published: June 04, 2026

Overcoming Resistance to Anti-EGFR Therapies: Mechanisms of Cetuximab and Panitumumab Resistance and Emerging Combination Strategies.

Overcoming Resistance to Anti-EGFR Therapies: Mechanisms of Cetuximab and Panitumumab Resistance and Emerging Combination Strategies.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 26, 2026

Conversion strategies in RAS wild-type colorectal liver metastases: a systematic review and meta-analysis of first-line trials comparing regimens with anti-epidermal growth factor receptor inhibitors versus bevacizumab.

Conversion strategies in RAS wild-type colorectal liver metastases: a systematic review and meta-analysis of first-line trials comparing regimens with anti-epidermal growth factor receptor inhibitors versus bevacizumab.

Journal: Critical reviews in oncology/hematology

Published: May 19, 2026

Differential Tumor Response and Conversion Outcomes Associated with First-Line Biologic Strategies in Liver-Limited RAS Wild-Type Metastatic Colorectal Cancer.

Differential Tumor Response and Conversion Outcomes Associated with First-Line Biologic Strategies in Liver-Limited RAS Wild-Type Metastatic Colorectal Cancer.

Journal: Oncology research

Published: May 07, 2026

Curative Resection of Rectal Cancer with Simultaneous Pulmonary and Hepatic Metastasis by Multidisciplinary Approach

Curative Resection of Rectal Cancer with Simultaneous Pulmonary and Hepatic Metastasis by Multidisciplinary Approach

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: May 07, 2026

A Case of Nephrotic Syndrome Developed during Anti-EGFR Antibody Combined Chemotherapy for Metastatic Colorectal Cancer

A Case of Nephrotic Syndrome Developed during Anti-EGFR Antibody Combined Chemotherapy for Metastatic Colorectal Cancer

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: May 07, 2026

Clinical Decision-Making and Multidisciplinary Management of Peristomal Pyoderma Gangrenosum in Stage IVB Rectal Cancer: A Case Report-Corticosteroid Response but Fatal Cancer Progression.

Clinical Decision-Making and Multidisciplinary Management of Peristomal Pyoderma Gangrenosum in Stage IVB Rectal Cancer: A Case Report-Corticosteroid Response but Fatal Cancer Progression.

Journal: Reports (MDPI)

Published: April 26, 2026

Non-Cisplatin Concurrent Systemic Therapy with Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: A Network Meta-Analysis of Randomized Clinical Trials.

Non-Cisplatin Concurrent Systemic Therapy with Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: A Network Meta-Analysis of Randomized Clinical Trials.

Journal: Cancers

Published: April 26, 2026

High therapeutic efficacy of triplet therapy in unresectable or metastatic colorectal cancer and its optimal application strategies.

High therapeutic efficacy of triplet therapy in unresectable or metastatic colorectal cancer and its optimal application strategies.

Journal: International journal of clinical oncology

Published: April 17, 2026

Showing 1-12 of 2,327

Last Updated: 09/26/2026